Martin Wilson Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

Martin Wilson is General Counsel of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 383,816 shares of RCKT, which is worth approximately $1.17 Million. The most recent transaction as insider was on Nov 18, 2025, when has been sold 1,646 shares (Common Stock) at a price of $2.98 per share, resulting in proceeds of $4,905. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 384K

34.45% 3M change

503.86% 12M change

Total Value Held $1.17 Million

Martin Wilson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2025	SELL Open market or private sale	$4,905 $2.98 p/Share	1,646 Reduced 0.43%	383,816 Common Stock
Nov 03 2025	BUY Grant, award, or other acquisition	-	100,000 Added 20.6%	385,462 Common Stock
Sep 08 2025	BUY Grant, award, or other acquisition	-	150,000 Added 34.45%	285,462 Common Stock
Aug 19 2025	SELL Open market or private sale	$1,764 $3.0 p/Share	588 Reduced 0.43%	135,462 Common Stock
Aug 18 2025	SELL Open market or private sale	$3,072 $3.06 p/Share	1,004 Reduced 0.73%	136,050 Common Stock
Aug 14 2025	SELL Open market or private sale	$36,569 $3.02 p/Share	12,109 Reduced 8.12%	137,054 Common Stock
May 20 2025	SELL Open market or private sale	$3,786 $6.45 p/Share	587 Reduced 0.39%	149,163 Common Stock

May 16 2025	SELL Open market or private sale	$6,177 $6.53 p/Share	946 Reduced 0.63%	149,750 Common Stock
Feb 21 2025	SELL Open market or private sale	$34,088 $10.58 p/Share	3,222 Reduced 2.09%	150,696 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	90,358 Added 36.99%	153,918 Common Stock
Nov 21 2024	SELL Open market or private sale	$15,333 $13.05 p/Share	1,175 Reduced 1.82%	63,560 Common Stock
Aug 16 2024	SELL Open market or private sale	$18,999 $18.5 p/Share	1,027 Reduced 1.56%	64,735 Common Stock
May 16 2024	SELL Open market or private sale	$24,470 $23.35 p/Share	1,048 Reduced 1.57%	65,762 Common Stock
May 14 2024	BUY Exercise of conversion of derivative security	-	2,420 Added 10.29%	21,100 Common Stock
Feb 29 2024	SELL Open market or private sale	$120,253 $29.33 p/Share	4,100 Reduced 18.0%	18,680 Common Stock
Feb 16 2024	SELL Open market or private sale	$106,707 $29.84 p/Share	3,576 Reduced 36.82%	6,136 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	16,644 Added 42.22%	22,780 Common Stock
Feb 14 2024	SELL Exercise of conversion of derivative security	-	9,712 Reduced 50.0%	9,712 Common Stock
Feb 14 2023	BUY Other acquisition or disposition	-	16,947 Added 20.23%	66,810 Common Stock
Aug 12 2022	BUY Other acquisition or disposition	-	28,763 Added 36.58%	49,863 Common Stock

Martin Wilson

General Counsel

Cranbury, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Value

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT

Account